To provide delivery system and regulatory support for Narcan, a needle-free, ready-to use medication, which can stop or reverse the effects of an opioid overdose
Aptar Pharma has partnered with Adapt Pharma to provided the delivery system and regulatory support for Narcan. Narcan is the first US FDA-approved nasally administered, needle-free, ready-to use medication can stop or reverse the effects of an opioid overdose. Narcan contains naloxone which is an opioid antagonist. It is marketed in the US for emergency treatment of known or suspected opioid overdose.
Aptar Pharma has brought to the partnership its unique experience in nasal drug delivery and regulatory expertise in relation to combination drug-device products successfully supporting Adapt Pharma’s new drug application.
The list of therapies successfully treated via the nasal route continues to grow from the traditional areas of migraine, osteoporosis and endometriosis, to now include: post-operative pain, cancer pain, osteoporosis, prostate cancer, urinary incontinence, anaemia and vaccinations.
EP News Bureau – Mumbai